|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 45.72 USD | -4.97% |
|
-14.17% | +55.04% |
| 05-19 | Moderna, Inc. Presents at RBC Capital Markets Global Healthcare Conference 2026, May-19-2026 10:00 AM | |
| 05-18 | US states reject anti-vaccine bills as public health groups fight MAHA | RE |
Company Valuation: Moderna, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 102,976 | 69,006 | 37,919 | 16,001 | 11,523 | 18,141 | - | - |
| Change | - | -32.99% | -45.05% | -57.8% | -27.99% | 57.44% | - | - |
| Enterprise Value (EV) 1 | 92,848 | 59,104 | 29,315 | 8,976 | 5,724 | 14,582 | 15,868 | 16,246 |
| Change | - | -36.34% | -50.4% | -69.38% | -36.23% | 154.76% | 8.82% | 2.38% |
| P/E ratio | 8.98x | 8.93x | -8.07x | -4.48x | -4.06x | -5.29x | -9.68x | -16x |
| PBR | 7.24x | 3.7x | 2.74x | 1.46x | 1.33x | 3.12x | 4.37x | 5.2x |
| PEG | - | -0.3x | 0x | 0.2x | 0.2x | -0.3x | 0.2x | 0.4x |
| Capitalization / Revenue | 5.58x | 3.58x | 5.54x | 4.94x | 5.93x | 8.69x | 7.22x | 5.65x |
| EV / Revenue | 5.03x | 3.07x | 4.28x | 2.77x | 2.94x | 6.99x | 6.32x | 5.06x |
| EV / EBITDA | 6.86x | 6.05x | -8.1x | -2.39x | -2x | -4.26x | -8.8x | -15.6x |
| EV / EBIT | 6.98x | 6.27x | -6.92x | -2.28x | -1.86x | -4.04x | -7.96x | -13.4x |
| EV / FCF | 6.96x | 12.9x | -7.66x | -2.21x | -2.77x | -4.81x | -10.2x | -12.7x |
| FCF Yield | 14.4% | 7.75% | -13% | -45.2% | -36.1% | -20.8% | -9.79% | -7.87% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 28.29 | 20.12 | -12.33 | -9.28 | -7.26 | -8.645 | -4.724 | -2.856 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 18,471 | 19,263 | 6,848 | 3,236 | 1,944 | 2,087 | 2,512 | 3,214 |
| EBITDA 1 | 13,528 | 9,768 | -3,618 | -3,756 | -2,859 | -3,425 | -1,804 | -1,042 |
| EBIT 1 | 13,296 | 9,420 | -4,239 | -3,945 | -3,074 | -3,611 | -1,994 | -1,209 |
| Net income 1 | 12,202 | 8,362 | -4,714 | -3,561 | -2,822 | -3,404 | -1,840 | -1,150 |
| Net Debt 1 | -10,128 | -9,902 | -8,604 | -7,025 | -5,799 | -3,559 | -2,273 | -1,895 |
| Reference price 2 | 253.98 | 179.62 | 99.45 | 41.58 | 29.49 | 45.72 | 45.72 | 45.72 |
| Nbr of stocks (in thousands) | 405,450 | 384,180 | 381,284 | 384,818 | 390,734 | 396,786 | - | - |
| Announcement Date | 2/24/22 A | 2/23/23 A | 2/22/24 A | 2/14/25 A | 2/13/26 A | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.28x | 6.99x | -4.26x | -.--% | 18.14B | |
| 16.32x | 3.54x | 9.55x | 0.62% | 64.13B | |
| 25.48x | 5.11x | 14.75x | 0.62% | 51.84B | |
| 32.69x | 11.16x | 20.66x | -.--% | 41.28B | |
| -125.91x | 2.76x | 8.16x | 4.11% | 33.94B | |
| 30.77x | 3.37x | 10.14x | -.--% | 28.13B | |
| 14.48x | 2.5x | 7.78x | -.--% | 19.1B | |
| 46.95x | 5.83x | 40.98x | -.--% | 17.72B | |
| 23.92x | 5.04x | 13.58x | -.--% | 15.96B | |
| -30.23x | 14.35x | -43.38x | -.--% | 12.93B | |
| Average | 2.92x | 6.06x | 7.80x | 0.54% | 30.32B | |
| Weighted average by Cap. | 4.33x | 5.56x | 10.70x | 0.7% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- MRNA Stock
- Valuation Moderna, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition